Emerging horizons for tick-borne pathogens: from the ‘one pathogen–one disease’ vision to the pathobiome paradigm by Vayssier-Taussat, Muriel et al.
  
Emerging horizons for tick-borne pathogens: from the "one pathogen-one 
disease" vision to the pathobiome paradigm 
 
 
Muriel Vayssier-Taussat1*, Maria Kazimirova2, Zdenek Hubalek3, Sándor Hornok4, 
Robert Farkas4, Jean-François Cosson1, Sarah Bonnet1, Gwenaël Vourch5, Patrick 
Gasqui5, Andrei Daniel Mihalca6, Olivier Plantard7, Cornelia Silaghi8, Sally Cutler9, 
Annapaola Rizzoli10 
 
 
1: INRA, UMR BIPAR,INRA,ANSES, ENVA Maisons-Alfort,France 
2: Institute of Zoology, Slovak Academy of Sciences, Bratislava, Slovakia 
3: Institute of Vertebrate Biology, Academy of Sciences of the Czech 
Republic ,v.v.i.,Brno, Czech Republic 
4: Department of Parasitology and Zoology, Faculty of Veterinary Science, Szent 
István University, Budapest, Hungary 
5: INRA, UR 346 Epidémiologie Animale, Saint Genès Champanelle, France 
6: University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 
department of Parasitology and Parasitic Diseases, Cluj-Napoca, Romania 
7: INRA, UMR 1300 BioEpAR, Nantes, France 
8: National Centre for Vector Entomology, Institute of Parasitology, Vetsuisse-Faculty, 
University of Zurich, Zürich, Switzerland 
9: University of East London, School of Health, Sport and Bioscience, London, UK 
10 :Fondazione Edmund Mach, Research and Innovation Centre, San Michele 
all’Adige, Trento, Italy 
 
Key words: Ixodes ricinus, emerging diseases, next generation sequencing, new 
paradigm, pathobiome, vector competence, co-infections, zoonoses, unknown 
pathogens. 
 
  
Abstract 
 
Ticks as vectors of several notorious zoonotic pathogens, represent an important and 
increasing threat for human, animal health in Europe. Recent application of new 
technology revealed the complexity of the tick microbiome that might impact upon its 
vectorial capacity. Appreciation of these complex systems is expanding our vision of 
tick-borne pathogens leading us to evolve a more integrated view that embraces the 
“pathobiome” representing the pathogenic agent integrated within its abiotic and 
biotic environments.  
In this review, we will explore how this new vision will revolutionize our understanding 
of tick-borne diseases. We will discuss the implications in terms of research 
approach for the future in order to efficiently prevent and control the threat posed by 
ticks.  
  
Recent application of next generation sequencing technology revealed the 
complexity of the tick microbiome that might impact upon its vectorial capacity and 
consequently affecting the vector-reservoir host interactions. Appreciation of these 
complex systems is expanding our vision of tick-borne pathogens leading us to 
evolve a more integrated view that embraces the “pathobiome” representing the 
pathogenic agent integrated within its abiotic and biotic environments including other 
pathogens, commensals, or mutualists. In this review, we will explore how this 
emerging vision of tick-borne pathogens will revolutionize our understanding of tick-
borne diseases which are a growing concern given their exponential increase since 
the discovery of the Lyme disease agent. We will discuss the implications in terms of 
research approach for the future in order to efficiently prevent and control the threat 
posed by ticks.   
 
CURRENT STATE OF THE ART KNOWLEDGE OF TICK-BORNE PATHOGENS 
USING “CONVENTIONAL VISION” 
  
Expanding horizons of Tick borne pathogens. In Europe, the most prevalent tick-
borne disease in humans is Lyme borreliosis (LB), caused by a group of bacteria 
belonging to the Borrelia burgdorferi sensu Iato group with at least 5 different species 
infecting humans in Europe [1]. Recently, B. miyamotoi, belonging to the more 
distantly related relapsing fever group, has been detected in patients in USA, Japan, 
Russia and The Netherlands [2-5] and is transmitted by the tick species involved in 
LB. Ticks can also be infected with other pathogens that might be transmitted to 
humans [6] (see Table 1). Amongst them, Anaplasma phagocytophilum is 
responsible for granulocytic anaplasmosis, Candidatus Neoerhlichia mikurensis has 
emerged as a cause of severe febrile illness in immunocompromised patients [7, 8], 
whilst rickettsiae of the spotted fever group are known (R. monacenis, R. conorii) or 
suspected (R. helvetica) to cause rickettsioses [9, 10]. Other bacterial pathogens 
such as Francisella tularensis, causing tularemia, and the Q fever agent Coxiella 
burnetii have also been detected in I. ricinus, but the direct role of this tick species in 
the epidemiology of these diseases is probably not significant [11, 12]. Humans may 
develop babesiosis following tick borne transmission of protozoans belonging to the 
genus Babesia, mainly B. divergens, however the virulence of additional members of 
this genus such as B. venatorum has recently been confirmed [13]. B. microti, an 
emerging human tick borne pathogen in USA, has also been identified in ticks in 
Europe, with one single human case to date [14]. Tick species also transmit 
arboviruses, the tick-borne encephalitis virus being the most notorious in terms of 
public health in Europe [15, 16]. Beside TBEV, many tick-borne viruses are known to 
be transmitted by other ticks. Among them, Crimean-Congo haemorrhagic fever virus 
(CCHFV) is considered to be one of the major emerging disease threats spreading 
within the European Union following an expanding distribution of its main tick vector, 
the genus Hyalomma [17]. More anecdotally, Omsk virus, an endemic virus from 
rural regions in Siberia and transmitted by Dermancentor species, is expanding its 
range. This virus caused capillary damage responsible for the haemorrhagic 
manifestations [15]. Other European tick-borne viruses are less well established as 
causes of disease but case reports are emerging. Among them, Powassan virus, a 
member of the genus Flavivirus, has been recovered from the brains of patients 
following fatal infection [15]. Louping ill virus, also member of the genus Flavivirus 
causes encephalitis in sheep, while exposed humans developed asymptomatic 
infection [15]. 
An increasing number of new species, strains or genetic variants of other 
microorganisms are being detected in ticks, resulting in an ever-increasing list of 
(potential) pathogens capable of infecting livestock, companion animals and humans. 
However, it needs to be taken into account that a significant portion of these "new" 
species/genotypes are not truly emerging, but only newly detected. This increasing 
recognition of pathogen biodiversity is not generating answers, but instead raising 
rather complex questions regarding ecological cycles of pathogens, their 
polymicrobial cross-talk, and their influence upon infection mechanisms, clinical 
differential diagnosis and intervention opportunities. 
Identification of microorganisms in ticks has been largely dominated by the use of 
conventional molecular approaches mostly using specific primers combined with 
(real-time) PCR, and less frequently by culture-dependent methods. However, 
pathogen detection in an arthropod is not sufficient to validate its vector competence. 
This entails use of vector competence studies to establish both the interaction of new 
or unexpected pathogen with ticks, and to evaluate the risk of exposure for both 
humans and animals. These types of studies require living ticks raised under 
controlled conditions. Because of their complex biological cycle and their feeding 
biology, maintenance of tick colonies and their infection with micro-organisms is not 
easy. However, several methods have been successfully developed and used to 
infect hard ticks with pathogens, e.g. feeding ticks on infected animals, injecting 
pathogens through the cuticule, by using thin capillary tubes, and feeding ticks on 
infected blood through artificial or animal-derived membranes [18]. These methods 
have been successfully employed to validate vector competence for a number of tick-
borne pathogens, including Lyme spirochaetes [19], A. phagocytophilum [20],  
Babesia sp. EU1 (or B. venatorum) [21] Bartonella sp. [22, 23] and Tick-borne 
encephalitis virus [24, 25]. However, for some established tick-borne pathogens such 
as Ca. N. mikurensis or R. helvetica (both of which currently lack any cultivable 
strain), the tick vector competence remains to be proven.  These are consequently 
considered “de facto” tick-borne pathogens under more or less strong 
“epidemiological evidence”.  
 
Diagnostic challenges posed by Tick borne Pathogens/Diseases. Given a clinical 
history of tick bites, Lyme borreliosis is the primary consideration, but in some this 
diagnosis remains elusive being unconfirmed by conventional serological tests [26]. 
People bitten by ticks can also be infected by tick-borne encephalitis virus (TBEV) 
causing severe encephalitis, which is readily diagnosed by serological tests [15]. TBE 
can be successfully prevented by active immunization, but no specific treatment is 
available [27]. As already mentioned, ticks are capable of transmitting the largest 
variety of pathogens amongst arthropod vectors, and pathogens other than the Lyme 
or tick-borne encephalitis agents might be involved in Tick Borne Diseases (TBD). 
Interestingly, the majority of those pathogens have been discovered during the last 
20 years. The symptoms induced by those pathogens are often mild and non-specific 
(high fever, fatigue, body aches, chills…) and can be confused with symptoms 
caused by infection with other agents. This is probably the underpinning reason why 
these infections are poorly recognised in humans by medical practitioners despite 
their abundance in ticks and/or reservoir animals. A striking example is that of B. 
miyamotoi. This Borrelia species was first isolated from Japanese Ixodes ticks in 
1995 whereby it was considered a non-pathogenic endogenous tick bacterium until 
the first human cases of B. miyamotoi infection were reported in Russia some sixteen 
years later [2]. Subsequently human infections have been described in the USA and 
most recently in the Netherlands [3-5, 28]. Circulation of B. miyamotoi between I. 
ricinus and wild animals has been confirmed in other European countries such as 
France, Estonia, Poland and Switzerland [29], which has confirmed that the French 
genotype is identical to an isolate from a Dutch patient [30]. Despite this apparent 
absence of human cases of B. miyamotoi infections among these countries, this is 
likely to reflect the absence of serological or molecular tests for B. miyamotoi 
combined with the lack of knowledge of these bacteria among medical practitioners. 
Thus, it is likely that the absence of human infections is rather due to missed 
diagnoses than to an actual absence of infection. 
Those patients bitten by ticks are additionally at risk for co-infection by several 
pathogens. For instance, Horowitz et al [31] described co-infection rates ranging from 
2 to 5% for Borrelia species and A. phagocytophilum among patients with erythema 
migrans, the diagnostic hallmark for Lyme borreliosis. Co-infections between B. 
afzelii and R. monacensis were also identified in skin biopsy of erythema migrans 
patients in The Netherlands [32]. However, co-infections are rarely diagnosed in 
routine practice, alerting us to the problem that co-infection in humans a relevant, 
albeit understudied issue, with important implications for public health. 
In consequence, people infected by pathogens other than Lyme borreliosis 
spirochaetes or TBEV, are rarely identified. In recent years, unexplained syndromes 
occurring after tick bites have became an increasingly important issue leading to 
considerable discord between scientists, patients and institutions of infectious 
disease.  
THE TECHNOLOGY-DRIVEN REVOLUTION OF TICK BORNE PATHOGEN’S 
VISION:  
From pathogen to pathobiome. Until now, most studies detecting pathogens in ticks 
have used assays able to assess only limited number of agents simultaneously [33, 
34]. This is partly due to technological limitations making complete screens of 
microorganisms in their natural vector/reservoir populations out of reach using 
standard laboratory procedures. Within the last few years, the rapid development of 
NGS methods has revolutionized the research field of epidemiology and diagnosis of 
infectious diseases facilitating complete screening of pathogens within their hosts, 
discovery of new pathogens, or the detection of unexpected ones. NGS has recently 
been successfully used to identify the bacterial communities associated with I. ricinus 
[35-38] based on the amplification and sequencing of hyper-variable regions of the 
16S rRNA encoding genes (metagenomic profile), revealing a highly diverse 
microbial community (108 genera representing all bacterial phyla). As expected, 
those approaches have allowed detection without a priori established tick-borne 
pathogens such as the Borrelia, Anaplasma, Coxiella, Francisella or Rickettsia genus. 
Among those genera, mostly known as pathogenic for vertebrates, whilst other 
species are considered as endosymbionts (e.g. the Rickettsia-endosymbiont of I. 
scapularis) [39] underscoring the challenge of differentiating between pathogens and 
endosymbionts. Adding further complexity, some authors consider Rickettsia species 
as endosymbionts that are transmitted vertically in arthropods, and only secondarily 
serve as pathogens of vertebrates [40]. For the Coxiella genus, the species C. 
burnetii is mostly considered as a vertebrate pathogen while numerous other Coxiella 
species have been found associated to ticks [41]. Phylogenetic analyses combined 
with experimental approaches suggested that these might also be considered as 
endosymbionts of ticks [11, 42]. Thus the pathogenic nature of C. burnetii could be 
rather an exception within the genus [43]. Beside the well-known vertebrate 
pathogenic species F. tularensis (occasionally found in ticks), Francisella-like-
endosymbionts associated with Dermacentor spp. have been described but their 
potential pathogenic nature remains to be investigated [44]. The Wolbachia and 
Arsenophonus genera are also bacteria associated to arthropods (mostly insects) 
and influence reproduction and/or immunity of their hosts [45, 46]. They have also 
been found associated within ticks [47]. However, a recent study revealed that in I. 
ricinus, the finding of Wolbachia is a consequence of parasitism by a parasitoid wasp 
(Ixodiphagus hookeri) [48]. The role of Arsenophonus as tick endosymbionts has still 
to be demonstrated. Finally, the endosymbiont Midichloria mitochondrii was initially 
observed within tick cells (especially in ovarian cells of I. ricinus; [49]. Use of 
molecular probes specific for this alphaproteobacteria have demonstrated their 
presence in almost 100% of I. ricinus females derived from natural populations [50], 
but also in other tick species [51]. Furthermore, M. mitochondri has recently been 
implicated as potential vertebrate pathogen [52].  
Use of NGS technology will undoubtedly shed new lights on the intriguing bacterial 
communities associated with ticks [37]. The clear-cut boundries between the so-
called “vertebrate-pathogens”, “arthropod-pathogens” or “arthropod-symbionts” may 
thus fade into a more dynamic and complex vision of bacterial-vector-vertebrate 
communities. Better knowledge of the role of these bacteria could even constitute 
useful resources for developing anti-vectorial control measures. 
Besides the known micro-organisms (either belonging to pathogens, endosymbionts 
or both), NGS also revealed that the majority of RNA/DNA sequences carried by ticks 
belonged to unknown micro-organisms. For instance, 80% of the viral nucleic 
sequences detected from tick extracts represented as-yet unidentified 
microorganisms (Vayssier-Taussat et al., unpublished data). Among these new viral 
sequences, we identified genera transmissible to humans and/or animals via 
arthropods, including Bunyaviridae (Nairovirus and Phlebovirus), Rhabdoviridae 
(Vesiculovirus) and Reoviridae (Coltivirus) (Vayssier-Taussat et al., unpublished 
data). A similar study undertaken by Lipkin et al. in the USA characterized the virome 
of different tick species. Powassan virus, a well-known human pathogenic tick-borne 
virus, and eight novel viruses belonging to nairovirus, phlebovirus and 
mononegavirus genera were identified among the three ticks assessed [53]. New 
viruses recently identified in ticks by NGS are listed in Table 2. 
By having sight of the entire tick microbial community, we can identify that pathogens 
are intimately associated to the vast community of micro-organisms (including other 
pathogens) and that by elucidating their influence tick biology, pathogen persistence, 
transmission, and virulence justifies the need to shift from the study of isolated 
pathogens to the more integrated approach. Within this context, we define the 
“pathobiome” as representing the pathogen within its abiotic and biotic environment 
[54] (See figure 1). Taking into account the multifactorial pathobiome requires 
comprehensive knowledge of the microbial community comprising the pathobiome, 
the network of interactions between microbes and the biological relevance of these 
interactions.  
Deciphering microbial interactions within the tick ecosystem   
Microbial interactions have largely been considered on a one-to-one interaction level, 
where the infection by one pathogen influences the acquisition of and/or dynamics of 
infection by a second pathogen. However, interactions between sets of pathogens 
are conceivable whereby different pathogens interact within a network or through 
“cascade consequence” [55, 56]. In experimental studies, one can investigate how 
the presence of one pathogen may interfere with infection by another, however, this 
is not possible using pathobiome perspective where many pathogens and other 
micro-organisms are present, including those member that remain poorly understood. 
In such a scenario, use of population studies assessing dynamics of change through 
the probability of finding those pathogens together beyond that which could occur by 
chance. Seeking microbial congruence initially assesses this, even though this can 
also result from confounding factors that create statistical associations between 
pathogens, without true biological interactions. In population studies, longitudinal or 
time series data are useful for identifying pathogen associations, identifying whether 
the presence of one pathogen modify subsequent infection by another [57]. However, 
such studies are resource-intensive. An alternative is to run one-off cross-sectional 
studies, which are cheaper and less time consuming than longitudinal studies. Cross-
sectional studies can easily be used to detect several pathogens and are especially 
appropriate in the case of emerging or poorly known pathogens or host species. In 
such cases, numerous approaches are available to detect pathogen associations. 
Multivariate analyses (e.g., PCA, FCA, DA, CoA) [58] will evaluate which pathogens 
tend to group together. However, statistical test associated with these analyses are 
usually not available [but see for example permutation methods, 59, 60]. A new 
modeling approach was develop, “the association screening approach” to detect the 
overall and more detailed multi-pathogen associations [61]. This method is quite 
powerful but would require over 1000 samples if we were to study over 10 micro-
organisms. Strong methodological developments on robust network analytical 
methods have been made [62] and continue to evolve (e.g. in medicine: metabolic 
pathways [63, 64], in computer science: peer to peer networks [65] or in social 
science: scientific collaboration [66]). They also offer an attractive representation of 
assessing dynamics of multiple pathogen relationships. They provide indices of 
association such as connectance [67], nestedness [68] or betweeness [69]. However, 
up to date, statistical tests regarding the networks parameters have rarely been used, 
but developments in this field are promising. 
Importance of the pathobiome concept to elucidate competence mechanisms: 
Microbes present along with pathogens in the ticks may interfere with pathogen 
transmission. For instance, Rickettsial endosymbionts are thought to alter 
transmission of other rickettsial pathogens, as seen by the inverse relationship 
between the infection prevalence of R. rickettsii (pathogen) and R. peacockii 
(symbiont) in Dermancentor andersoni [47, 70]. Furthermore, the presence of 
Coxiella-related symbionts in the salivary glands of Amblyomma ticks impairs 
transmission of Ehrlichia chaffeensis [71]. In addition to symbionts, ticks are also 
colonized by a natural bacterial microbiota mainly belonging to the Proteobacteria, 
Firmicutes, and Bacteroides phyla [72]. It has also been demonstrated that these tick 
microbiomes can interfere with pathogens. For example, when ticks were bred in a 
sterile environment, the absence of microbiota altered gut integrity and the ability of B. 
burgdorferi to colonize [72]. Microbiome alterations might also result in a modulated 
immune response which might then interfere with pathogen survival and infection, as 
shown for other arthropod vectors [73]. Thus taking into account the pathobiome 
rather than the isolated pathogens is crucial to understand how pathogens are 
transmitted and how they survive within ticks. 
 
  
PATHOBIOME APPROACH FOR SURVEILLANCE, DIAGNOSIS AND 
PREVENTION OF TICK BORNE DISEASES  
Surveillance and Diagnosis. Considering the vast number of potential tick borne 
pathogens that can result in disease, either alone or in association, there is an urgent 
need to develop methods that are capable to accommodate this diversity, but also 
provide insights into the biology of tick-borne pathogens. For instance, many tick-
borne pathogens colonize blood (residing within either intra- or extracellular niches) 
of vertebrate hosts. Thus it makes sense to detect the presence of their DNA in the 
blood of infected human patients of animals. However, blood infection does not occur 
for all tick-borne pathogens. A notable exception is the Lyme spirochaete that does 
not stably infect blood of human hosts, therefore detection of DNA in the blood of 
patient bitten by ticks is unhelpful necessitating use of more specific samples (such 
as skin biopsies) or use of serological tests even though their specificity and 
sensitivity are not always optimal. Molecular identification of tick-borne pathogens 
has been mostly based on the use of specific primers combined with real-time PCR, 
which can only detect a selected and limited number of species simultaneously. To 
overcome these limitations, new tools enabling high-throughput monitoring of tick-
borne pathogens were an urgent priority. Based upon NGS data on presence of tick-
borne pathogens in ticks in different European geographical regions, we developed a 
microfluidigm system allowing multiple parallel real-time PCRs for TBD surveillance 
that might be adapted to diagnostic settings [74]. This has the unique ability to 
simultaneously analyze multiple pathogens (up to 48 different species) in the same 
sample. This new tool presents the major advantage and can be easily adapted to 
new or emerging situations as it is entirely possible to remove primers/probes sets in 
order to modify the panel of targeted pathogens. If developed by private companies, 
this approach will represent an important improvement for the diagnosis of TBD. 
Vaccination. Given the vast number of pathogens/potential pathogens that could be 
transmitted by the same tick species, deployment of tick vaccines would be both 
smart and environmentally friendly alternative to protect human and animal 
population against tick-borne diseases. This novel approach for control of vector 
infestations and thus reducing subsequent pathogen transmission necessitates a 
deep understanding of microbial interactions within the tick. For that purpose, 
research on molecular interactions between ticks and pathogens as well as the 
identification of suitable targets for vaccine development are major challenges for the 
implementation of new TBD control strategies [75]. Among these, target molecules 
playing key roles in vector capacity are particularly promising [76]. To date, the only 
commercially available anti-tick vaccine is based on the R. microplus midgut protein 
BM86, interfering with tick feeding and subsequent egg production [77]. However, 
thanks to technological advances for tick infection combined with improved resolution 
of molecular investigative methods, further promising candidates have recently been 
identified. These include tick proteins derived from I. ricinus [78, 79], I. scapularis [80], 
Rhipicephalus microplus [81, 82], as well as candidates common to several hard tick 
species [83]. Improving our understanding of molecular interactions between ticks 
and tick-borne pathogens is an essential prerequisite for conception of future 
generations of vaccines and for vectors and diseases control. 
  
Conclusion 
The tick pathobiome vision, thanks to powerful molecular and technological 
advancements offers now a new vantage point to understand tick-borne pathogens in 
a more holistic point of view. 
  
Future perspective 
Shifting the paradigm from pathogens to pathobiome will have many research 
consequences; the most important being 1) how to determine the significance of 
microorganisms revealed by next generation sequencing technology in human and/or 
animal idiopathic disease following tick bites; 2) to decipher the impact of complex 
microbial interactions between pathogens and/or other tick endogenous micro-
organisms that might influence pathogen transmission, persistence, virulence and 
evolution. Based upon this new knowledge, new research avenues will have to be 
followed to develop adequate strategies to better diagnose and combat tick-borne 
diseases 
  
EXECUTIVE SUMMARY 
Current Knowledge on Tick-borne pathogens: 
 An increasing number of “new” species, strains or genetic variants of 
microorganisms are being detected in ticks, resulting in an ever-increasing list 
of potential pathogens.  
 This increasing recognition of pathogen diversity is raising complex questions 
regarding ecological cycles of pathogen, polymicrobial cross-talk, diagnosis 
and intervention opportunities. 
The new vision: 
 Next generation technology shed new lights on bacterial communities 
associated with ticks. 
 The majority of DNA/RNA sequences carried by ticks belong to unknown 
microorganisms.  
 Pathogens are intimately associated with the tick microbial community. 
 This justifies the need to shift from the study of isolated pathogens to a more 
integrated pathobiome approach. 
Future research directions in term of surveillance, diagnosis and prevention of 
tick borne diseases: 
 New tools enabling high-throughput monitoring of tick-borne pathogens are an 
urgent priority 
 Given the vast number of pathogens that could be transmitted by the same 
tick species, deployment of tick vaccines would be a smart and 
environmentally friendly alternative to protect human and animal population 
against tick borne diseases. 
 
  
Acknowledgment:  
 
The authors thank the community of enthusiastic scientists exploring new insights in 
ticks and tick-borne pathogens in Europe, specially the ones participating to Edenext 
project and the COST action Eurnegvec. 
 
  
Table 1: The predominant tick species present in North hemisphere, the pathogens 
they transmit, associated diseases, animal hosts as well as animal reservoirs of the 
corresponding pathogens.  
Ticks species   Pathogens  Diseases (hosts)  Reservoirs 
Ixodes species Borrelia burgdorferi sensu lato Lyme Disease (human, cattle, dog, horse) Rodent, bird, 
reptile 
Borrelia miyamotoi Recurrent fever Rodent, bird 
Anaplasma phagocytophilum Granulocytic Anaplasmosis (Flu-like 
symptoms in human, cattle, goat, sheep, 
horse, dog, cat) 
Wild  ruminants,  
Rodent, 
Babesia divergens Babesiosis (Human, cattle) Deer, cattle 
Babesia microti Babesiosis (Human) rodent 
Babesia venatorum   
Babesia capreoli   
Coxiella burnetii  Q fever (human, goat, sheep…) Rodent 
Francisella tularensis Tularemia (human, rodents sheep, goat, …) Hare 
Bartonella henselae Bartonellosis (human) Cat 
Bartonella berkhoffii Bartonellosis (Dog, human) Dog 
Tick-borne encephalitis Virus TBE (human, dog) Rodent 
Candidatus Neoehrlichia 
mikurensis 
Fever (human, dogs) Rodent 
Rickettsia helvetica (suspected) Fever (human)?* Unknown 
Rickettsia monacensis Fever (Human) Unknown 
Powassan virus Fever, neurological signs (Human) Rodent 
Louping hill virus Encephalitis (Human, sheep) Mountain hare, 
sheep 
Dermacentor spp.  Anaplasma ovis Anaplasmosis (goat, sheep) Unknown 
Babesia caballi Babesiosis (horse) Horse 
Theileria/Babesia equi Theileriosis (horse) Horse 
Babesia canis Canine Babesiois Dogs 
Rickettsia slovaca TIBOLA/SENLAT (human) Unknown 
Rickettsia raoultii TIBOLA/SENLAT (human) Unknown 
Anaplasma marginale Bovine anaplasmosis (Cattle) Cattle 
Francisella tularensis Tularemia (human, rodents sheep, goat, …) Hare 
Coxiella burnetii  Q fever (human, goat, sheep…) Rodent 
Omsk haemorrhagic virus Haemorrhagic manifestations (Human) Muskrat 
Powassan virus Fever, neurological signs (Human) Rodent 
Haemaphysalis spp.  Babesia spp. Babesiosis (human, possibly cattle and dog) Unknown 
Theileria spp. Theileriosis (cattle) Unknown 
Hyalomma spp.  Theileria annulata Theileriosis (Cattle) Unknown 
Theileria equi   
Crimean-Congo hemorrhagic Fever 
Virus* 
Hemorrhagic fever (human)* Rodent, bird? 
Rhipicephalus sanguineus  Rickettsia conorii Mediterranean spotted fever (human) Dog? 
Ehrlichia canis Ehrlichiosis (dog) Dog 
Anaplasma platys Cyclic thrombocytopenia Dog 
Babesia vogeli/canis Canine Babesiosis Dog 
Hepatozoon canis Hepatozoonosis Dog 
Babesia gibsoni Canine Babesiosis Dog 
  
 Table 2: New viruses recently identified in ticks by NGS.  
 
Viruses Diseases Tick species  references 
Nairovirus (South Bay virus) Unknown I. scapularis [53] 
Blacklegged tick Phlebovirus 
(BTPV) 
Unknown I. scapularis [53] 
American dog tick Phlebovirus 
(ADTPV) 
Unknown I. scapularis/D. variabilis [53] 
Monongavirales-like virus Unknown I. scapularis [53] 
Phlebovirus (Hearltand virus) Severe febrile illness A. americanum [84] 
Shibuinji virus (New tick borne 
virus phlebovirus) 
unknwon Rhipicephalus spp. [85] 
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Figure Legend: 
Figure 1. The tick pathobiome concept. 
